Grifols opens US$100m worldwide operations facility in Dublin, Ireland
Will contain a warehouse and handle labelling, packaging and final conditioning for plasma, intermediate and finished product
Spanish firm Grifols, the world's third-largest plasma product manufacturer, has officially opened its US$100m Bioscience Division global operations centre in Ireland.
Located at Grange Castle Business Park Dublin, the 22,000m2 operation will contain a warehouse and handle labelling, packaging and final conditioning for plasma, intermediate and finished products. It will also house regulatory and quality activities for plasma and plasma derivatives, as well as have a R&D global management office and administrative, commercial and financial operations.
The operation will house the central warehouse for all plasma coming from the US, as it has the capacity to store up to 1,150 pallets at –30ºC, and is equipped with quality control laboratories.
It will also be the central warehouse for intermediate and finished products, with capacity to store up to 3,000 pallets of products at a temperature of +5ºC.
It has four labelling and packing lines and Grifols expects to process about 10 million product vials in 2016. This amount will double in the long term.
The centre is scheduled to be operational during the first half of 2016 and will generate approximately 140 jobs.
Grifols' Bioscience Division generated sales revenue of €2.5bn in 2014, or 75% of the group's total net revenue. It manufactures plasma proteins and focuses on promoting its therapeutic use.
Grifols says the project is the result of a growth strategy that has placed a strong emphasis on the internationalisation and globalisation of activities. The company generated 93.4% of its sales outside Spain in 2014, and the company currently has direct commercial presence in 30 countries and distributes its products in 100.
